1
|
Farhat H, Alinier G, Helou M, Galatis I, Bajow N, Jose D, Jouini S, Sezigen S, Hafi S, Mccabe S, Somrani N, Aifa KE, Chebbi H, Amor AB, Kerkeni Y, Al-Wathinani AM, Abdulla NM, Jairoun AA, Morris B, Castle N, Al-Sheikh L, Abougalala W, Dhiab MB, Laughton J. Perspectives on Preparedness for Chemical, Biological, Radiological, and Nuclear Threats in the Middle East and North Africa Region: Application of Artificial Intelligence Techniques. Health Secur 2024; 22:190-202. [PMID: 38335443 DOI: 10.1089/hs.2023.0093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2024] Open
Abstract
Over the past 3 decades, the diversity of ethnic, religious, and political backgrounds worldwide, particularly in countries of the Middle East and North Africa (MENA), has led to an increase in the number of intercountry conflicts and terrorist attacks, sometimes involving chemical and biological agents. This warrants moving toward a collaborative approach to strengthening preparedness in the region. In disaster medicine, artificial intelligence techniques have been increasingly utilized to allow a thorough analysis by revealing unseen patterns. In this study, the authors used text mining and machine learning techniques to analyze open-ended feedback from multidisciplinary experts in disaster medicine regarding the MENA region's preparedness for chemical, biological, radiological, and nuclear (CBRN) risks. Open-ended feedback from 29 international experts in disaster medicine, selected based on their organizational roles and contributions to the academic field, was collected using a modified interview method between October and December 2022. Machine learning clustering algorithms, natural language processing, and sentiment analysis were used to analyze the data gathered using R language accessed through the RStudio environment. Findings revealed negative and fearful sentiments about a lack of accessibility to preparedness information, as well as positive sentiments toward CBRN preparedness concepts raised by the modified interview method. The artificial intelligence analysis techniques revealed a common consensus among experts about the importance of having accessible and effective plans and improved health sector preparedness in MENA, especially for potential chemical and biological incidents. Findings from this study can inform policymakers in the region to converge their efforts to build collaborative initiatives to strengthen CBRN preparedness capabilities in the healthcare sector.
Collapse
Affiliation(s)
- Hassan Farhat
- Hassan Farhat, MRes, MSc, is a Quality Improvement Mentor, Quality Patient Safety and Risk Management, Ambulance Service Group, Hamad Medical Corporation, Doha, Qatar; PhD Candidate, Faculty of Medicine "Ibn El Jazzar," University of Sousse, Sousse, Tunisia; and PhD Candidate, Faculty of Sciences, University of Sfax, Sfax, Tunisia, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Guillaume Alinier
- Guillaume Alinier, PhD, MPhys (Hons), PGCert, SFHEA, NTF, is Director of Research, Ambulance Service, Hamad Medical Corporation, Doha, Qatar; Visiting Professor, School of Health and Social Work, University of Hertfordshire, Hatfield, UK; Adjunct Professor, Weill Cornell Medicine-Qatar, Doha, Qatar; and Visiting Professor, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Mariana Helou
- Mariana Helou, MD, MSc DM, is a Clinical Assistant Professor and Clerkship Director of Emergency Room, Division Head of Emergency Medicine, Internal Medicine Department - Emergency, Medicine Gilbert and Rose-Marie Chagoury School of Medicine, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Ionnais Galatis
- Ionnais Galatis, Brigadier General (ret.), MD, MSc, MC, is an MD Consultant in Allergy & Clinical Immunology, Medical/Hospital/Ops CBRNE Planner/Instructor, Senior Asymmetric Threats Analyst, and Research Associate, Center for Security Studies (KEMEA), Athens, Greece; Manager, CBRN Knowledge Center, International CBRNE Institute, Brussels, Belgium; and Senior Advisor, Research Institute for European and American Studies, Alimos, Greece, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Nidaa Bajow
- Nidaa Bajow, MD, PhD, is Disaster Medicine Coordinator and Disaster Medicine Training Supervisor, Disaster Medicine Unit, Emergency Department Security Force Hospital Riyadh, Saudi Arabia, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Denis Jose
- Denis Jose, Pharm D, PhD, is Colonel, Head, Pharmaceutical Services, and Technical Adviser on Toxicological and CBRNE Risk Management, Alpes-Maritimes Fire and Rescue Services, Paris, France, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Sarra Jouini
- Sarra Jouini, MD, is Emergency Coordinator, Emergency Department, Charles Nicolle Hospital, and an Associate Professor, EL Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Sermet Sezigen
- Sermet Sezigen, MD, PhD, is an Associate Professor, Department of Medical CBRN Defense, University of Health Sciences, Ankara, Turkey, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Samia Hafi
- Samia Hafi, MD, is Head of SAMU(EMS), Hospital of Gabes, Gabes, Tunisia, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Sheena Mccabe
- Sheena Mccabe, MSc, is a Consultant Lecture for BSc in Crisis and Emergency Management, Ras Laffan Emergency and Safety College, Ras Laffan, Qatar, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Naoufel Somrani
- Naoufel Somrani, MD, is General Director of Public Health Facilities, Ministry of Health, Tunis, Tunisia, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Kawther El Aifa
- Kawther El Aifa, MSc, is a Quality Management/Improvement Reviewer, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Henda Chebbi
- Henda Chebbi, MD, is Assistant Director of Emergency Medicine Unit, Strategic Health Operations Center (SHOCR Room), Emergency Medicine Directorate, Ministry of Health, Tunis, Tunisia, at King Saud University, Riyadh, Saudi Arabia
| | - Asma Ben Amor
- Asma Ben Amor, MRes, is a Paramedicine Professor, Higher School of Health Sciences and Technologies of Sousse, and a PhD Candidate, Faculty of Medicine "Ibn El Jazzar," University of Sousse, Sousse, Tunisia, at King Saud University, Riyadh, Saudi Arabia
| | - Yosra Kerkeni
- Yosra Kerkeni, MD, is Emergency Coordinator, Emergency Medicine, Ministry of Health, Tunis, Tunisia, at King Saud University, Riyadh, Saudi Arabia
| | - Ahmed M Al-Wathinani
- Ahmed M. Al-Wathinani, MHA, PhD, is Vice Dean of Academic Affairs, College of Applied, Business Administration; Chairman of the Emergency Medical Services Department; Associate Professor of Emergency and Disaster Management, Prince Sultan Bin Abdulaziz College for Emergency Medical Services, at King Saud University, Riyadh, Saudi Arabia
| | - Nassem Mohammed Abdulla
- Nassem Mohammed Abdulla, PhD, is Head of Department, Health and Safety Department, Dubai Municipality, Dubai, United Arab Emirates, in Doha, Qatar
| | - Ammar Abdulrahman Jairoun
- Ammar Abdulrahman Jairoun, PhD, is Senior Consumables Material Inspection Officer, Health and Safety Department, Dubai Municipality, Dubai, United Arab Emirates; and Head of Department, Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia, in Doha, Qatar
| | - Brendon Morris
- Brendon Morris, MRes, MTec, is Executive Director, Major Incident Planning and Resilience, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Nicholas Castle
- Nicholas Castle, PhD FIMC, is Interim Executive Director, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Loua Al-Sheikh
- Loua Al-Sheikh, MBChB, BSc(Hons), FRCA, is Medical Director, The Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Walid Abougalala
- Walid Abougalala, MBBS, EMDM, JMC(EM), MSc, MAo, MEdu, is a Consultant Emergency Preparedness and Response Department, Ministry of Public Health; Chairman, Corporate Facility Management and Safety Committee; and Consultant Emergency and Disaster Medicine, Hamad Medical Corporation, in Doha, Qatar
| | - Mohamed Ben Dhiab
- Mohamed Ben Dhiab, MD, is Vice Dean, Academic Affairs, Faculty of Medicine "Ibn El Jazzar," University of Sousse, and Professor of Forensic and Legal Medicine, Farhat Hached Academic Hospital, Sousse, Tunisia
| | | |
Collapse
|
2
|
Thakur A, Patwa J, Pant S, Jeet Singh Flora S, Sharma A. Synthesis and evaluation of small organic molecule as reactivator of organophosphorus inhibited acetylcholinesterase. Drug Chem Toxicol 2024; 47:26-41. [PMID: 36514993 DOI: 10.1080/01480545.2022.2150210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2022] [Revised: 11/08/2022] [Accepted: 11/16/2022] [Indexed: 12/15/2022]
Abstract
A series of uncharged salicylaldehyde oximes were synthesized and evaluated for the reactivation of organophosphorus (OP) nerve agents simulants Diethylchlorophosphonate (DCP) & Diethylcyanophosphonate (DCNP) and pesticides (paraoxon & malaoxon) inhibited electric eel Acetylcholinesterase (AChE). The computational software Swiss ADME and molinspiration were used to unfold the probability of drug-likeness properties of the oximes derivatives. Substituted aromatic oximes with diethylamino or bromo group with free hydroxyl group ortho to oxime moiety were found efficient to regenerate the enzymatic activity in in-vitro AChE assay. The alkylation of the ortho hydroxyl group of derivatives led to the loss of reactivation potential. The derivatives with a hydroxyl group and without oxime group and vice versa did not show significant reactivation potency against tested OP toxicants. Further, we also evaluated the reactivation potential of these selected molecules on the rat brain homogenate against different OPs inhibited ChE and found maximum reactivation potency of oxime 2e. The in-vitro results were further validated by molecular docking and dynamic studies which showed that the hydroxyl group interacted with serine amino acids in the catalytic anionic site of AChE enzyme and was stable up to 200 ns consequently providing proper orientation to oxime moiety for reactivating the OP inhibited enzyme. It has thus been proved by the structure-activity relationship of oximes derivatives that hydroxyl group ortho to oxime is essential for reactivating OP inhibited electric eel AChE. Amongst the twenty-one oximes derivatives, 2e was found to be most active in regenerating the paraoxon, malaoxon, DCP and DCNP inhibited AChE enzyme.
Collapse
Affiliation(s)
- Ashima Thakur
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Raebareli, India
| | - Jayant Patwa
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, India
| | - Suyash Pant
- Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Kolkata, India
| | - Swaran Jeet Singh Flora
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, India
| | - Abha Sharma
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Raebareli, India
| |
Collapse
|
3
|
François S, Mondot S, Gerard Q, Bel R, Knoertzer J, Berriche A, Cavallero S, Baati R, Orset C, Dal Bo G, Thibault K. Long-Term Anxiety-Like Behavior and Microbiota Changes Induced in Mice by Sublethal Doses of Acute Sarin Surrogate Exposure. Biomedicines 2022; 10:biomedicines10051167. [PMID: 35625901 PMCID: PMC9138233 DOI: 10.3390/biomedicines10051167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Revised: 05/07/2022] [Accepted: 05/16/2022] [Indexed: 12/10/2022] Open
Abstract
Anxiety disorder is one of the most reported complications following organophosphorus (OP) nerve agent (NA) exposure. The goal of this study was to characterize the long-term behavioral impact of a single low dose exposure to 4-nitrophenyl isopropyl methylphosphonate (NIMP), a sarin surrogate. We chose two different sublethal doses of NIMP, each corresponding to a fraction of the median lethal dose (one mild and one convulsive), and evaluated behavioral changes over a 6-month period following exposure. Mice exposed to both doses showed anxious behavior which persisted for six-months post-exposure. A longitudinal magnetic resonance imaging examination did not reveal any anatomical changes in the amygdala throughout the 6-month period. While no cholinesterase activity change or neuroinflammation could be observed at the latest timepoint in the amygdala of NIMP-exposed mice, important modifications in white blood cell counts were noted, reflecting a perturbation of the systemic immune system. Furthermore, intestinal inflammation and microbiota changes were observed at 6-months in NIMP-exposed animals regardless of the dose received. This is the first study to identify long-term behavioral impairment, systemic homeostasis disorganization and gut microbiota alterations following OP sublethal exposure. Our findings highlight the importance of long-term care for victims of NA exposure, even in asymptomatic cases.
Collapse
Affiliation(s)
- Sabine François
- Department of Radiation Biological Effects, Armed Forces Biomedical Research Institute, 91220 Bretigny sur Orge, France; (S.F.); (S.C.)
| | - Stanislas Mondot
- Micalis Institute, AgroParisTech, Université Paris-Saclay, INRAE, 78350 Jouy-en-Josas, France;
| | - Quentin Gerard
- Department of Toxicology and Chemical Risks, Armed Forces Biomedical Research Institute, 91220 Bretigny sur Orge, France; (Q.G.); (R.B.); (J.K.); (A.B.)
- Institut Blood and Brain@caen-normandie Cyceron, Caen-Normandie University, UNICAEN, INSERM, UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), 14000 Caen, France;
| | - Rosalie Bel
- Department of Toxicology and Chemical Risks, Armed Forces Biomedical Research Institute, 91220 Bretigny sur Orge, France; (Q.G.); (R.B.); (J.K.); (A.B.)
| | - Julie Knoertzer
- Department of Toxicology and Chemical Risks, Armed Forces Biomedical Research Institute, 91220 Bretigny sur Orge, France; (Q.G.); (R.B.); (J.K.); (A.B.)
| | - Asma Berriche
- Department of Toxicology and Chemical Risks, Armed Forces Biomedical Research Institute, 91220 Bretigny sur Orge, France; (Q.G.); (R.B.); (J.K.); (A.B.)
- CEA, 92260 Fontenay aux Roses, France
| | - Sophie Cavallero
- Department of Radiation Biological Effects, Armed Forces Biomedical Research Institute, 91220 Bretigny sur Orge, France; (S.F.); (S.C.)
| | - Rachid Baati
- ICPEES UMR CNRS 7515, Institut de Chimie des Procédés, pour l’Energie, l’Environnement, et la Santé, 67000 Strasbourg, France;
| | - Cyrille Orset
- Institut Blood and Brain@caen-normandie Cyceron, Caen-Normandie University, UNICAEN, INSERM, UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), 14000 Caen, France;
| | - Gregory Dal Bo
- Department of Toxicology and Chemical Risks, Armed Forces Biomedical Research Institute, 91220 Bretigny sur Orge, France; (Q.G.); (R.B.); (J.K.); (A.B.)
- Correspondence: (G.D.B.); (K.T.)
| | - Karine Thibault
- Department of Toxicology and Chemical Risks, Armed Forces Biomedical Research Institute, 91220 Bretigny sur Orge, France; (Q.G.); (R.B.); (J.K.); (A.B.)
- Correspondence: (G.D.B.); (K.T.)
| |
Collapse
|
4
|
Backer BS, Meek EC, Ross MK, Chambers JE. Pharmacokinetics of three novel pyridinium aldoxime acetylcholinesterase reactivators in female rats. Toxicol Appl Pharmacol 2022; 446:116046. [PMID: 35550885 DOI: 10.1016/j.taap.2022.116046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Revised: 04/29/2022] [Accepted: 05/01/2022] [Indexed: 10/18/2022]
Abstract
A platform of novel lipophilic substituted phenoxyalkyl pyridinium oximes was invented to reactivate organophosphate-inhibited acetylcholinesterase. This platform has provided superior efficacy in rats to the current standard of care, 2-PAM, for survival of lethal doses of nerve agent surrogates as well as evidence of brain penetration and neuroprotection. The pharmacokinetics of three of these novel oximes in female rats was studied for comparison to previous data in male rats. Compared to the published half-life of 2-PAM (less than 2 h), the lead novel oxime, Oxime 20, displayed a plasma half-life of about 5 h in both sexes of rats following intramuscular administration. Very few sex differences in pharmacokinetic parameters were apparent. Oxime 20 displayed an increase in brain concentration to plasma concentration over the initial 2 h following intramuscular administration in male rats, with a plateau at 1 h; there were no differences in brain concentrations between the sexes at 2 h. Hepatic metabolism of Oxime 20 was higher in rat microsomes than in human microsomes. The relatively long plasma half-life is likely an important factor in both the enhanced survival and the neuroprotection previously observed for Oxime 20. The metabolism data suggest that the clearance of Oxime 20 could be slower in humans than was observed in rats, which might allow less frequent administration than 2-PAM for therapy of organophosphate acute toxicity. Therefore, the pharmacokinetic data combined with our earlier efficacy data suggest that Oxime 20 has potential as a superior therapeutic for nerve agent poisoning.
Collapse
Affiliation(s)
- Brian S Backer
- College of Veterinary Medicine, Department of Comparative Biomedical Sciences, Center for Environmental Health Sciences, Mississippi State University, Mississippi State, MS 39762, United States of America
| | - Edward C Meek
- College of Veterinary Medicine, Department of Comparative Biomedical Sciences, Center for Environmental Health Sciences, Mississippi State University, Mississippi State, MS 39762, United States of America
| | - Matthew K Ross
- College of Veterinary Medicine, Department of Comparative Biomedical Sciences, Center for Environmental Health Sciences, Mississippi State University, Mississippi State, MS 39762, United States of America
| | - Janice E Chambers
- College of Veterinary Medicine, Department of Comparative Biomedical Sciences, Center for Environmental Health Sciences, Mississippi State University, Mississippi State, MS 39762, United States of America.
| |
Collapse
|
5
|
Da Silva O, Probst N, Landry C, Hanak AS, Warnault P, Coisne C, Calas AG, Gosselet F, Courageux C, Gastellier AJ, Trancart M, Baati R, Dehouck MP, Jean L, Nachon F, Renard PY, Dias J. A New Class of Bi- and Trifunctional Sugar Oximes as Antidotes against Organophosphorus Poisoning. J Med Chem 2022; 65:4649-4666. [PMID: 35255209 PMCID: PMC8958973 DOI: 10.1021/acs.jmedchem.1c01748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Recent events demonstrated that organophosphorus nerve agents are a serious threat for civilian and military populations. The current therapy includes a pyridinium aldoxime reactivator to restore the enzymatic activity of acetylcholinesterase located in the central nervous system and neuro-muscular junctions. One major drawback of these charged acetylcholinesterase reactivators is their poor ability to cross the blood-brain barrier. In this study, we propose to evaluate glucoconjugated oximes devoid of permanent charge as potential central nervous system reactivators. We determined their in vitro reactivation efficacy on inhibited human acetylcholinesterase, the crystal structure of two compounds in complex with the enzyme, their protective index on intoxicated mice, and their pharmacokinetics. We then evaluated their endothelial permeability coefficients with a human in vitro model. This study shed light on the structural restrains of new sugar oximes designed to reach the central nervous system through the glucose transporter located at the blood-brain barrier.
Collapse
Affiliation(s)
- Ophélie Da Silva
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, F-91220 Brétigny-Sur-Orge, France
| | - Nicolas Probst
- Normandie Université, COBRA, UMR 6014 & FR 3038, Université de Rouen, INSA Rouen, CNRS, 1 rue Tesnière, 76821 Mont-Saint-Aignan Cedex, France
| | - Christophe Landry
- Université d'Artois (UArtois), UR 2465, LBHE Laboratoire de la Barrière Hémato-Encéphalique, F-62307 Lens, France
| | - Anne-Sophie Hanak
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, F-91220 Brétigny-Sur-Orge, France
| | - Pierre Warnault
- Normandie Université, COBRA, UMR 6014 & FR 3038, Université de Rouen, INSA Rouen, CNRS, 1 rue Tesnière, 76821 Mont-Saint-Aignan Cedex, France
| | - Caroline Coisne
- Université d'Artois (UArtois), UR 2465, LBHE Laboratoire de la Barrière Hémato-Encéphalique, F-62307 Lens, France
| | - André-Guilhem Calas
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, F-91220 Brétigny-Sur-Orge, France
| | - Fabien Gosselet
- Université d'Artois (UArtois), UR 2465, LBHE Laboratoire de la Barrière Hémato-Encéphalique, F-62307 Lens, France
| | - Charlotte Courageux
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, F-91220 Brétigny-Sur-Orge, France
| | - Anne-Julie Gastellier
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, F-91220 Brétigny-Sur-Orge, France
| | - Marilène Trancart
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, F-91220 Brétigny-Sur-Orge, France
| | - Rachid Baati
- Institut de Chimie et Procédés pour l'Énergie, l'Environnement, et la Santé: UMR CNRS 7515 ICPEES, Université de Strasbourg - École de Chimie Polymères et Matériaux, ECPM 25 rue Becquerel, 67087 Strasbourg cedex 2, France
| | - Marie-Pierre Dehouck
- Université d'Artois (UArtois), UR 2465, LBHE Laboratoire de la Barrière Hémato-Encéphalique, F-62307 Lens, France
| | - Ludovic Jean
- Normandie Université, COBRA, UMR 6014 & FR 3038, Université de Rouen, INSA Rouen, CNRS, 1 rue Tesnière, 76821 Mont-Saint-Aignan Cedex, France
| | - Florian Nachon
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, F-91220 Brétigny-Sur-Orge, France
| | - Pierre-Yves Renard
- Normandie Université, COBRA, UMR 6014 & FR 3038, Université de Rouen, INSA Rouen, CNRS, 1 rue Tesnière, 76821 Mont-Saint-Aignan Cedex, France
| | - José Dias
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, F-91220 Brétigny-Sur-Orge, France
| |
Collapse
|
6
|
Dhuguru J, Zviagin E, Skouta R. FDA-Approved Oximes and Their Significance in Medicinal Chemistry. Pharmaceuticals (Basel) 2022; 15:66. [PMID: 35056123 PMCID: PMC8779982 DOI: 10.3390/ph15010066] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Revised: 12/28/2021] [Accepted: 12/30/2021] [Indexed: 01/16/2023] Open
Abstract
Despite the scientific advancements, organophosphate (OP) poisoning continues to be a major threat to humans, accounting for nearly one million poisoning cases every year leading to at least 20,000 deaths worldwide. Oximes represent the most important class in medicinal chemistry, renowned for their widespread applications as OP antidotes, drugs and intermediates for the synthesis of several pharmacological derivatives. Common oxime based reactivators or nerve antidotes include pralidoxime, obidoxime, HI-6, trimedoxime and methoxime, among which pralidoxime is the only FDA-approved drug. Cephalosporins are β-lactam based antibiotics and serve as widely acclaimed tools in fighting bacterial infections. Oxime based cephalosporins have emerged as an important class of drugs with improved efficacy and a broad spectrum of anti-microbial activity against Gram-positive and Gram-negative pathogens. Among the several oxime based derivatives, cefuroxime, ceftizoxime, cefpodoxime and cefmenoxime are the FDA approved oxime-based antibiotics. Given the pharmacological significance of oximes, in the present paper, we put together all the FDA-approved oximes and discuss their mechanism of action, pharmacokinetics and synthesis.
Collapse
Affiliation(s)
- Jyothi Dhuguru
- Mitchell Cancer Institute, University of South Alabama, 1660 SpringHill Avenue, Mobile, AL 36604, USA;
| | - Eugene Zviagin
- Department of Chemistry, University of Michigan, 930 N. University Avenue, Ann Arbor, MI 48109, USA;
| | - Rachid Skouta
- Department of Biology, University of Massachusetts, Amherst, MA 01003, USA
| |
Collapse
|
7
|
Angrand L, Takillah S, Malissin I, Berriche A, Cervera C, Bel R, Gerard Q, Knoertzer J, Baati R, Kononchik JP, Megarbane B, Thibault K, Dal Bo G. Persistent brainwave disruption and cognitive impairment induced by acute sarin surrogate sub-lethal dose exposure. Toxicology 2021; 456:152787. [PMID: 33887375 DOI: 10.1016/j.tox.2021.152787] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2021] [Revised: 04/11/2021] [Accepted: 04/15/2021] [Indexed: 11/15/2022]
Abstract
Warfare neurotoxicants such as sarin, soman or VX, are organophosphorus compounds which irreversibly inhibit cholinesterase. High-dose exposure with nerve agents (NA) is known to produce seizure activity and related brain damage, while less is known about the effects of acute sub-lethal dose exposure. The aim of this study was to characterize behavioral, brain activity and neuroinflammatory modifications at different time points after exposure to 4-nitrophenyl isopropyl methylphosphonate (NIMP), a sarin surrogate. In order to decipher the impacts of sub-lethal exposure, we chose 4 different doses of NIMP each corresponding to a fraction of the median lethal dose (LD50). First, we conducted a behavioral analysis of symptoms during the first hour following NIMP challenge and established a specific scoring scale for the intoxication severity. The intensity of intoxication signs was dose-dependent and proportional to the cholinesterase activity inhibition evaluated in mice brain. The lowest dose (0.3 LD50) did not induce significant behavioral, electrocorticographic (ECoG) nor cholinesterase activity changes. Animals exposed to one of the other doses (0.5, 0.7 and 0.9 LD50) exhibited substantial changes in behavior, significant cholinesterase activity inhibition, and a disruption of brainwave distribution that persisted in a dose-dependent manner. To evaluate long lasting changes, we conducted ECoG recording for 30 days on mice exposed to 0.5 or 0.9 LD50 of NIMP. Mice in both groups showed long-lasting impairment of theta rhythms, and a lack of restoration in hippocampal ChE activity after 1-month post-exposure. In addition, an increase in neuroinflammatory markers (IBA-1, TNF-α, NF-κB) and edema were transiently observed in mice hippocampus. Furthermore, a novel object recognition test showed an alteration of short-term memory in both groups, 1-month post-NIMP intoxication. Our findings identified both transient and long-term ECoG alterations and some long term cognitive impairments following exposure to sub-lethal doses of NIMP. These may further impact morphopathological alterations in the brain.
Collapse
Affiliation(s)
- Loïc Angrand
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France; EnvA, IMRB, Maisons-Alfort, France; Université Paris-Est Créteil, INSERM, Team Relaix, Créteil, France
| | - Samir Takillah
- Departement of Neuroscience, Unit of Fatigue and Vigilance, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France; VIFASOM Team (EA 7330), Paris Descartes University, Sorbonne Paris Cité, Hôtel Dieu, Paris, France
| | - Isabelle Malissin
- Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology APHP, Paris-Diderot University, INSERM UMRS-1144, Paris, France
| | - Asma Berriche
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France; CEA, Fontenay aux roses, France
| | - Chloe Cervera
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France
| | - Rosalie Bel
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France
| | - Quentin Gerard
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France; Normandie University, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France
| | - Julie Knoertzer
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France
| | - Rachid Baati
- ICPEES UMR CNRS 7515, Institut de Chimie des Procédés, pour l'Energie, l'Environnement, et la Santé, Strasbourg, France
| | - Joseph P Kononchik
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France
| | - Bruno Megarbane
- VIFASOM Team (EA 7330), Paris Descartes University, Sorbonne Paris Cité, Hôtel Dieu, Paris, France; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology APHP, Paris-Diderot University, INSERM UMRS-1144, Paris, France
| | - Karine Thibault
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France.
| | - Gregory Dal Bo
- Departement of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny sur Orge, France.
| |
Collapse
|
8
|
Thakur A, Patil P, Sharma A, Flora S. Advances in the Development of Reactivators for the Treatment of Organophosphorus Inhibited Cholinesterase. CURR ORG CHEM 2020. [DOI: 10.2174/1385272824999201020203544] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Organophosphorus Compounds (OPCs) are used as pesticides to control pest, as
chemical weapons in military conflict and unfortunately in the terrorist attack. These compounds
are irreversible inhibitors of acetylcholinesterase, resulting in the accumulation of
acetylcholine that leads to severe health complications which may be ended with the death of
the victim. Current antidotes used for reactivation of organophosphorus inhibited acetylcholinesterase
(OP-AChE) are not able to cross the blood-brain barrier efficiently, therefore being
incapable to reactivate OP-AChE of the central nervous system. Due to limitations with
current antidotes, there is an urgent need for new effective antidotes that could be included in
the treatment regimen of OP poisoning. In this direction, comprehensive work has been done
to improve the permeability of existing antidotes using a variety of strategies that include
synthesis of oxime bonded to peripheral site binding moiety via an alkyl, aryl, or heteroatom-containing linker, synthesis
of sugar oximes, and prodrug of 2-PAM, incorporating fluorine and chlorine in the structure of charged oximes.
Other classes of compounds such as the mannich base, N-substituted hydroxyimino acetamide, alkylating
agents, have been investigated for reactivation of OP-AChE. This review comprises the development of various
classes of reactivators with the aim of either enhancing blood-brain permeability of existing antidotes or discovering
a new class of reactivators.
Collapse
Affiliation(s)
- Ashima Thakur
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Raebareli, India
| | - Pooja Patil
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Raebareli, India
| | - Abha Sharma
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Raebareli, India
| | - S.J.S. Flora
- Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, India
| |
Collapse
|
9
|
Garcia JM, Meek EC, Chambers JE. Novel pyridinium oximes enhance 24-h survivability against a lethal dose of nerve agent surrogate in adult female rats. Toxicology 2020; 446:152626. [PMID: 33159982 DOI: 10.1016/j.tox.2020.152626] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Revised: 10/08/2020] [Accepted: 11/01/2020] [Indexed: 02/06/2023]
Abstract
Our laboratory has developed novel substituted phenoxyalkyl pyridinium oximes (US Patent 9,227,937) designed to more efficiently penetrate the central nervous system to enhance survivability and attenuate seizure-like signs and neuropathology. Previous studies with male Sprague-Dawley rats indicated that survivability was enhanced against the nerve agent (sarin) surrogate, 4-nitrophenyl isopropyl methylphosphonate (NIMP). In this study, female adult Sprague-Dawley rats, tested specifically in diestrus, were challenged subcutaneously with lethal concentrations of NIMP (0.6 mg/kg). After development of seizure-like behavior and other signs of cholinergic toxicity, human equivalent dosages of atropine (0.65 mg/kg) and one of four oximes (2-PAM, or novel oxime 15, 20, or 55; 0.146 mmol/kg) or Multisol vehicle was administered alone or in binary oxime combinations intramuscularly. Animals were closely monitored for signs of cholinergic toxicity and 24 h survivability. Percentages of animals surviving the 24 h NIMP challenge dose were 35 % for 2-PAM and 55 %, 70 %, and 25 % for novel oximes 15, 20, and 55, respectively. Improvements in survival were also observed over 2-PAM alone with binary combinations of 2-PAM and either oxime 15 or oxime 20. Additionally, administration of novel oximes decreased the duration of seizure-like behavior as compared to 2-PAM suggesting that these oximes better penetrate the blood-brain barrier to mitigate central nervous system hypercholinergic activity. Efficacies were similar between females and previously reported males. These data indicate that the novel pyridinium oximes enhance survivability against lethal OP toxicity as compared to 2-PAM in adult female rats.
Collapse
Affiliation(s)
- Jason M Garcia
- Center for Environmental Health Sciences, Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, P.O. Box 6100, Mississippi State, MS, 39762, USA.
| | - Edward C Meek
- Center for Environmental Health Sciences, Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, P.O. Box 6100, Mississippi State, MS, 39762, USA.
| | - Janice E Chambers
- Center for Environmental Health Sciences, Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, P.O. Box 6100, Mississippi State, MS, 39762, USA.
| |
Collapse
|
10
|
Sakurada K, Ohta H. No promising antidote 25 years after the Tokyo subway sarin attack: A review. Leg Med (Tokyo) 2020; 47:101761. [DOI: 10.1016/j.legalmed.2020.101761] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2020] [Revised: 06/26/2020] [Accepted: 07/10/2020] [Indexed: 10/23/2022]
|
11
|
Understanding the Interaction Modes and Reactivity of Trimedoxime toward MmAChE Inhibited by Nerve Agents: Theoretical and Experimental Aspects. Int J Mol Sci 2020; 21:ijms21186510. [PMID: 32899591 PMCID: PMC7554915 DOI: 10.3390/ijms21186510] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2020] [Revised: 08/31/2020] [Accepted: 09/02/2020] [Indexed: 11/17/2022] Open
Abstract
Organophosphorus (OP) compounds are used as both chemical weapons and pesticides. However, these agents are very dangerous and toxic to humans, animals, and the environment. Thus, investigations with reactivators have been deeply developed in order to design new antidotes with better efficiency, as well as a greater spectrum of action in the acetylcholinesterase (AChE) reactivation process. With that in mind, in this work, we investigated the behavior of trimedoxime toward the Mus musculus acetylcholinesterase (MmAChE) inhibited by a range of nerve agents, such as chemical weapons. From experimental assays, reactivation percentages were obtained for the reactivation of different AChE–OP complexes. On the other hand, theoretical calculations were performed to assess the differences in interaction modes and the reactivity of trimedoxime within the AChE active site. Comparing theoretical and experimental data, it is possible to notice that the oxime, in most cases, showed better reactivation percentages at higher concentrations, with the best result for the reactivation of the AChE–VX adduct. From this work, it was revealed that the mechanistic process contributes most to the oxime efficiency than the interaction in the site. In this way, this study is important to better understand the reactivation process through trimedoxime, contributing to the proposal of novel antidotes.
Collapse
|
12
|
Rosenberg Y, Saxena A. Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs. Neuropharmacology 2020; 174:108150. [PMID: 32442543 PMCID: PMC7365266 DOI: 10.1016/j.neuropharm.2020.108150] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2020] [Revised: 05/05/2020] [Accepted: 05/14/2020] [Indexed: 10/24/2022]
Abstract
More frequent and widespread nerve agent attacks highlight the need for efficacious pre- and post-exposure organophosphate (OP) counter-measures to protect military and civilian populations. Because of critical targeting of acetylcholinesterase (AChE) in the CNS by OPs, a pre-treatment candidate for preventing/reducing poisoning will be a broadly acting molecule that scavenges OPs in blood before they reach their physiological targets. Prophylactic human butyrylcholinesterase (HuBChE), the leading pretreatment candidate, has been shown to protect against multiple LD50's of nerve agents in rodents, macaques, and minipigs. This review describes the development of a HuBChE bioscavenger pretreatment from early proof-of-concept studies to pre-clinical studies with the native injectable enzyme and the development of aerosolized forms of recombinant enzyme, which can be delivered by inhalation nebulizer devices, to effect protection against inhaled OP nerve agents and insecticides. Early animal studies utilized parenteral exposure. However, lungs are the portal of entry for most volatile OP vapors and represent the major means of OP intoxication. In this regard, pretreat-ment with 7.5 mg/kg of HuBChE by IM injection protected minipigs against lethal sarin vapor and prevented AChE inhibition in the blood. This is similar to the five-day protection in macaques by an aerosolized rHuBChE using a nebulizer against aerosolized paraoxon (estimated to be an 8 mg/kg estimated human dose). Importantly, lethal inhaled doses of OP may be smaller relative to the same dose delivered by injection, thus reducing the protective HuBChE dose, while a combination of HuBChE and post-exposure oxime may prolong protection.
Collapse
Affiliation(s)
| | - Ashima Saxena
- U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA
| |
Collapse
|
13
|
Worek F, Thiermann H, Wille T. Organophosphorus compounds and oximes: a critical review. Arch Toxicol 2020; 94:2275-2292. [PMID: 32506210 PMCID: PMC7367912 DOI: 10.1007/s00204-020-02797-0] [Citation(s) in RCA: 83] [Impact Index Per Article: 20.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Accepted: 05/28/2020] [Indexed: 12/19/2022]
Abstract
Organophosphorus (OP) pesticides and nerve agents still pose a threat to the population. Treatment of OP poisoning is an ongoing challenge and burden for medical services. Standard drug treatment consists of atropine and an oxime as reactivator of OP-inhibited acetylcholinesterase and is virtually unchanged since more than six decades. Established oximes, i.e. pralidoxime, obidoxime, TMB-4, HI-6 and MMB-4, are of insufficient effectiveness in some poisonings and often cover only a limited spectrum of the different nerve agents and pesticides. Moreover, the value of oximes in human OP pesticide poisoning is still disputed. Long-lasting research efforts resulted in the preparation of countless experimental oximes, and more recently non-oxime reactivators, intended to replace or supplement the established and licensed oximes. The progress of this development is slow and none of the novel compounds appears to be suitable for transfer into advanced development or into clinical use. This situation calls for a critical analysis of the value of oximes as mainstay of treatment as well as the potential and limitations of established and novel reactivators. Requirements for a straightforward identification of superior reactivators and their development to licensed drugs need to be addressed as well as options for interim solutions as a chance to improve the therapy of OP poisoning in a foreseeable time frame.
Collapse
Affiliation(s)
- Franz Worek
- Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany.
| | - Horst Thiermann
- Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Timo Wille
- Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany
| |
Collapse
|
14
|
Chambers JE, Meek EC. Central neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates. Ann N Y Acad Sci 2020; 1479:5-12. [PMID: 32319115 DOI: 10.1111/nyas.14352] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2019] [Revised: 03/20/2020] [Accepted: 03/26/2020] [Indexed: 01/09/2023]
Abstract
Oximes remain a long-standing element of the therapy for nerve agents, organophosphates (OPs) that poison by inhibiting the enzyme acetylcholinesterase (AChE), resulting in hypercholinergic activity both centrally and peripherally. Oximes, such as the pyridinium oxime pralidoxime (2-PAM) in the United States, can reactivate the inhibited AChE and restore cholinergic function. However, there are several drawbacks to the current oximes; one of them, the inability of these oximes to effectively enter the brain, is the subject of study by several laboratories, including ours. Our laboratory invented a platform of substituted phenoxyalkyl pyridinium oximes that were tested against highly relevant surrogates of the nerve agents, sarin and VX. Using high sublethal dosages of the OPs, the novel oximes were observed to attenuate seizure-like behavior in rats and to reduce the levels of glial fibrillary acidic protein (an indicator of glial scarring) to control levels, in contrast to levels observed with 2-PAM or no oxime therapy. Using lethal levels of surrogates, some novel oximes protected against lethality compared with 2-PAM, shortened the time to cessation of seizure-like behavior (from 8+ to 6 h), and protected the brain neurons. Therefore, some of these novel oximes are showing exceptional promise alone or in combination with 2-PAM as therapeutics against nerve agent toxicity.
Collapse
Affiliation(s)
- Janice E Chambers
- Center for Environmental Health Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi
| | - Edward C Meek
- Center for Environmental Health Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi
| |
Collapse
|
15
|
Gorecki L, Gerlits O, Kong X, Cheng X, Blumenthal DK, Taylor P, Ballatore C, Kovalevsky A, Radić Z. Rational design, synthesis, and evaluation of uncharged, "smart" bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase. J Biol Chem 2020; 295:4079-4092. [PMID: 32019865 PMCID: PMC7105318 DOI: 10.1074/jbc.ra119.012400] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2019] [Revised: 02/03/2020] [Indexed: 01/05/2023] Open
Abstract
Organophosphate (OP) intoxications from nerve agent and OP pesticide exposures are managed with pyridinium aldoxime-based therapies whose success rates are currently limited. The pyridinium cation hampers uptake of OPs into the central nervous system (CNS). Furthermore, it frequently binds to aromatic residues of OP-inhibited acetylcholinesterase (AChE) in orientations that are nonproductive for AChE reactivation, and the structural diversity of OPs impedes efficient reactivation. Improvements of OP antidotes need to include much better access of AChE reactivators to the CNS and optimized orientation of the antidotes' nucleophile within the AChE active-center gorge. On the basis of X-ray structures of a CNS-penetrating reactivator, monoxime RS194B, reversibly bound to native and venomous agent X (VX)-inhibited human AChE, here we created seven uncharged acetamido bis-oximes as candidate antidotes. Both oxime groups in these bis-oximes were attached to the same central, saturated heterocyclic core. Diverse protonation of the heterocyclic amines and oxime groups of the bis-oximes resulted in equilibration among up to 16 distinct ionization forms, including uncharged forms capable of diffusing into the CNS and multiple zwitterionic forms optimal for reactivation reactions. Conformationally diverse zwitterions that could act as structural antidote variants significantly improved in vitro reactivation of diverse OP-human AChE conjugates. Oxime group reorientation of one of the bis-oximes, forcing it to point into the active center for reactivation, was confirmed by X-ray structural analysis. Our findings provide detailed structure-activity properties of several CNS-directed, uncharged aliphatic bis-oximes holding promise for use as protonation-dependent, conformationally adaptive, "smart" accelerated antidotes against OP toxicity.
Collapse
Affiliation(s)
- Lukas Gorecki
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093-0751
| | - Oksana Gerlits
- Bredesen Center, University of Tennessee, Knoxville, Tennessee 37996
| | - Xiaotian Kong
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Ohio State University, Columbus, Ohio 43210
| | - Xiaolin Cheng
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Ohio State University, Columbus, Ohio 43210
| | - Donald K Blumenthal
- Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah 84112
| | - Palmer Taylor
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093-0751
| | - Carlo Ballatore
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093-0751
| | - Andrey Kovalevsky
- Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831
| | - Zoran Radić
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093-0751.
| |
Collapse
|
16
|
Jett DA, Galanopoulou AS, Moshé SL. Preface: Discovery and development of better medical countermeasures for chemical threats targeting the nervous system. Neurobiol Dis 2020; 133:104557. [PMID: 31374245 PMCID: PMC6904429 DOI: 10.1016/j.nbd.2019.104557] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Affiliation(s)
- David A Jett
- National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA.
| | - Aristea S Galanopoulou
- Isabelle Rapin Division of Child Neurology, Saul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Laboratory of Developmental Epilepsy, Comprehensive Einstein/Montefiore Epilepsy, Albert Einstein College of Medicine, Bronx, NY, USA.
| | - Solomon L Moshé
- Isabelle Rapin Division of Child Neurology, Saul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Laboratory of Developmental Epilepsy, Comprehensive Einstein/Montefiore Epilepsy, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA.
| |
Collapse
|
17
|
Andrýs R, Klusoňová A, Lísa M, Žd'árová Karasová J. Encapsulation of oxime acetylcholinesterase reactivators: influence of physiological conditions on the stability of oxime-cucurbit[7]uril complexes. NEW J CHEM 2020. [DOI: 10.1039/d0nj03102j] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
The influence of physiological conditions on the host–guest chemistry of oxime acetylcholinesterase reactivators with cucurbit[7]urile was investigated to increase their effectiveness for the treatment of organophosphate intoxication.
Collapse
Affiliation(s)
- Rudolf Andrýs
- Department of Chemistry
- Faculty of Science
- University of Hradec Králové
- 50003 Hradec Králové
- Czech Republic
| | - Aneta Klusoňová
- Department of Chemistry
- Faculty of Science
- University of Hradec Králové
- 50003 Hradec Králové
- Czech Republic
| | - Miroslav Lísa
- Department of Chemistry
- Faculty of Science
- University of Hradec Králové
- 50003 Hradec Králové
- Czech Republic
| | - Jana Žd'árová Karasová
- Department of Toxicology and Military Pharmacy
- Faculty of Military Health Sciences Hradec Králové
- University of Defence
- Praha
- Czech Republic
| |
Collapse
|